Dashboard
Manage Tickers

BNTX BioNTech SE

Nasdaq biontech.de


$ 105.00 $ 0.00 (0 %)    

Friday, 24-Oct-2025 04:43:06 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.94 $ 0.00 (0 %)
DIA $ 468.00 $ 0.00 (0 %)
SPY $ 674.10 $ 0.00 (0 %)
TLT $ 91.35 $ 0.00 (0 %)
GLD $ 374.50 $ 0.00 (0 %)
$ 104.75
$ 105.18
$ 103.50 x 150
$ 105.46 x 127
-- - --
$ 81.20 - $ 129.27
719,226
na
25.14M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-neutral-on-biontech-lowers-price-target-to-120
JP Morgan Maintains Neutral on BioNTech, L...
10/23/2025 16:05:44

JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Neutral and lowers the price target from $121 to $120.

Core News & Articles
BioNTech Commences Public Exchange Offer F...
10/22/2025 10:51:57

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherap...

beyond-the-numbers-7-analysts-discuss-biontech-stock
Beyond The Numbers: 7 Analysts Discuss Bio...
10/10/2025 21:01:36

morgan-stanley-maintains-overweight-on-biontech-lowers-price-target-to-131
Morgan Stanley Maintains Overweight on Bio...
10/10/2025 17:35:02

Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:BNTX) with a Overweight and lowers the price target from $13...

Core News & Articles
'Exclusive: RFK Jr cancelled mRNA research...
09/24/2025 14:49:35

https://www.nature.com/articles/d41586-025-03093-6

jp-morgan-maintains-neutral-on-biontech-raises-price-target-to-121
JP Morgan Maintains Neutral on BioNTech, R...
09/22/2025 12:24:10

JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Neutral and raises the price target from $116 to $121.

Core News & Articles
U.S. CDC Vaccine Panel Set To Vote On Covi...
09/19/2025 19:34:23

- Reuters 

Core News & Articles
U.S. CDC Vaccine Advisers Vote To Pass Upd...
09/19/2025 19:33:28

- Reuters

moderna-reports-8-fold-jump-in-antibodies-with-updated-spikevax
Moderna Reports 8-Fold Jump In Antibodies ...
09/16/2025 14:49:52

Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in h...

synopsys-chewy-and-the-trade-desk-are-among-top-10-large-cap-losers-last-week-sep-8--sep-12-are-the-others-in-your-portfolio
Synopsys, Chewy, And The Trade Desk Are Am...
09/14/2025 15:01:21

Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and The Trade Desk—while biote...

pfizer-moderna-biontech-stocks-tumble-after-report-of-plan-to-link-covid-vaccines-to-child-deaths
Pfizer, Moderna, BioNTech Stocks Tumble Af...
09/12/2025 19:33:54

Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump a...

Core News & Articles
U.S. HHS Says Until Vaccine Safety Data Is...
09/12/2025 16:46:09

- Reuters

Core News & Articles
'Trump officials to link child deaths to c...
09/12/2025 15:45:15

https://www.washingtonpost.com/health/2025/09/12/covid-vaccine-child-death-cdc/

pfizer-biontech-roll-out-covid-19-update-that-boosts-antibodies-4-fold-in-high-risk-adults
Pfizer, BioNTech Roll Out COVID-19 Update ...
09/08/2025 18:13:05

Pfizer and BioNTech's LP.8.1 COVID-19 vaccine boosts antibodies 4-fold in high-risk adults, with no new safety concerns rep...

biontech-bristol-myers-squibb-show-tumor-shrinkage-in-lung-cancer-immunotherapy
BioNTech, Bristol Myers Squibb Show Tumor ...
09/08/2025 18:01:24

BioNTech and Bristol Myers report strong interim results for pumitamig plus chemo in lung cancer, showing high response rates.

Core News & Articles
BioNTech, Bristol Myers Squibb Present Int...
09/08/2025 15:03:24

PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activit...

what-analysts-are-saying-about-biontech-stock
What Analysts Are Saying About BioNTech Stock
09/08/2025 13:01:38

hc-wainwright--co-reiterates-buy-on-biontech-maintains-136-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
09/08/2025 11:50:50

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $136 price target.

Core News & Articles
Pfizer And BioNTech Announced Topline Resu...
09/08/2025 10:48:37

Phase 3 clinical trial cohort of adults 65+ and 18-64 with at least one underlying risk condition shows at least a 4-fold incre...

guidewire-software-samsara-zumiez-and-other-big-stocks-moving-higher-on-friday
Guidewire Software, Samsara, Zumiez And Ot...
09/05/2025 17:29:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION